Profil
Lida Pacaud is currently Chief Executive & Medical Officer at Ichnos Glenmark Innovation, Inc. starting in 2025.
Formerly, Dr. Pacaud was Vice President-Clinical Development at Legend Biotech Corp.
from 2021 to 2023 and Head-Global Clinical Program at Novartis International AG from 2013 to 2021.
Education includes a doctorate from Tbilisi State Medical University.
Aktive Positionen von Lida Pacaud
| Unternehmen | Position | Beginn |
|---|---|---|
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Vorstandsvorsitzender | 06.12.2025 |
Ehemalige bekannte Positionen von Lida Pacaud
| Unternehmen | Position | Ende |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2023 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | 01.01.2021 |
Ausbildung von Lida Pacaud
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Tbilisi State Medical University
Tbilisi State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















